Skip to Main Content
research
nutrition
Cancer
Reporting from the frontiers of health and medicine
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

UnitedHealth executive to head health insurance group AHIP

  • Rachel Cohrs

By Rachel Cohrs Dec. 11, 2023

Reprints
The front of the Capitol Hill, illuminated in dim yellow sunlight under dark blue sky — exclusive coverage from STAT
STEFANI REYNOLDS/AFP via Getty Images

WASHINGTON — An executive at insurance giant UnitedHealth Group is slated to be the next leader of the health insurance industry’s largest lobbying group, the group announced Monday.

AHIP has selected Mike Tuffin, who’s currently UnitedHealth’s senior vice president for external affairs and head of U.S. government affairs, to be its next leader, after Matt Eyles announced his retirement from the group earlier this year after a five-year tenure.

advertisement

Notably, UnitedHealth group is not a member of AHIP after the company left in 2015.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

About the Author Reprints

Rachel Cohrs

Rachel Cohrs

Washington Correspondent

Rachel Cohrs reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying, and federal agencies. Her primary areas of focus are the pharmaceutical and hospital industries. She is also the co-author of the free, twice-weekly D.C. Diagnosis newsletter.

Tags

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.

FDA authorizes new drug to protect immune compromised from…
FDA authorizes new drug to protect immune compromised from Covid-19
Drug development was once a marathon. New tools and…
Drug development was once a marathon. New tools and timelines are turning it into a sprint
A study says intermittent fasting is making people drop…
A study says intermittent fasting is making people drop dead. Oh, come on
How biotech investors spot opportunity when stocks are down…
How biotech investors spot opportunity when stocks are down — and up
How a for-profit health system’s push to expand ended…
How a for-profit health system’s push to expand ended in disappointment for a tiny island nation
Despite new Wegovy coverage, Medicare patients may face high…
Despite new Wegovy coverage, Medicare patients may face high drug costs and other hurdles

Recommended Stories